Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has...
-
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (NASDAQ: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the...
-
COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today unveiled its lineup of headliner products and bold innovation bets for spring...
-
CHICAGO and VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis...
-
VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and...
-
Eliminated substantially all of the Company’s debt, ended the year with $6.8 million in Cash and $8.2 million of Stockholders’ Equity.Fourth Quarter Revenue increased 12% sequentially, and Fourth...
-
NEW YORK and LEAMINGTON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (NASDAQ: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...
-
Cannara Releases Q2 FY26 Results: $27.2M revenue, 43% GM, $6.0M Adj. EBITDA, OCF $2.9M; 4.4% national share, #1 Québec; Valleyfield expansion progressing.
-
Transaction further strengthens the Company’s balance sheet with approximately US$110 million of combined cash and net working capital Consideration of 213 million shares at a deemed price of US$0.60...
-
Ethos Cannabis will close on 4/20 swapping holiday discounts for employee appreciation and a month-long patient education campaign.